Literature DB >> 29223542

Interval exercise training increases LIF expression and prevents myocardial infarction-induced skeletal muscle atrophy in rats.

Dandan Jia1, Mengxin Cai1, Yue Xi1, Shaojun Du2.   

Abstract

AIMS: Myocardial infarction (MI) is commonly associated with body weight loss and skeletal muscle atrophy. Studies have shown that exercise training could give beneficial effects on skeletal muscle growth. Leukemia inhibitory factor (LIF) is a key regulator of muscle growth and regeneration. The aim of this study was to investigate the effects of interval exercise training (IET) on the expression of LIF and the MI-induced skeletal muscle atrophy. MAIN
METHODS: Male Sprague-Dawley rats were used to establish the MI model by ligation of the left anterior descending coronary artery. Infarcted Rats were divided into two groups: sedentary MI group (MI) and MI with interval exercise group (ME), and compared to sham-operated group (Sham). Exercise-trained animals were subjected to eight weeks of IET. Cardiac function, collagen volume fraction, expression of LIF and its receptor LIFR, myofiber size, apoptosis and proliferation in gastrocnemius muscle were analyzed. KEY
FINDINGS: IET increased heart functional performance and was accompanied with reversing cardiac pathological remodeling. Moreover, IET increased the expression of LIF and LIFR, activated signal transducer and activator of transcription (STAT3), reduced apoptosis and promoted proliferation in gastrocnemius muscle compared with the MI group. In addition, there was a significant negative correlation between skeletal muscle atrophy and LIF expression which was stimulated by IET in infarcted rats. SIGNIFICANCE: IET reverses MI-induced cardiac dysfunction and skeletal muscle atrophy. In addition, IET up-regulates the expression of muscle LIF/LIFR and activates the STAT3.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interval exercise training; Leukemia inhibitory factor; Myocardial infarction; Skeletal muscle atrophy

Mesh:

Substances:

Year:  2017        PMID: 29223542     DOI: 10.1016/j.lfs.2017.12.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Leukaemia inhibitory factor in gastric cancer: friend or foe?

Authors:  Lornella Seeneevassen; Océane C B Martin; Philippe Lehours; Pierre Dubus; Christine Varon
Journal:  Gastric Cancer       Date:  2022-02-02       Impact factor: 7.370

Review 2.  Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications.

Authors:  Sandra Maria Barbalho; Uri Adrian Prync Flato; Ricardo José Tofano; Ricardo de Alvares Goulart; Elen Landgraf Guiguer; Cláudia Rucco P Detregiachi; Daniela Vieira Buchaim; Adriano Cressoni Araújo; Rogério Leone Buchaim; Fábio Tadeu Rodrigues Reina; Piero Biteli; Daniela O B Rodrigues Reina; Marcelo Dib Bechara
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

3.  Osteoblast and Osteoclast Activity Affect Bone Remodeling Upon Regulation by Mechanical Loading-Induced Leukemia Inhibitory Factor Expression in Osteocytes.

Authors:  Jingke Du; Jiancheng Yang; Zihao He; Junqi Cui; Yiqi Yang; Mingming Xu; Xinhua Qu; Ning Zhao; Mengning Yan; Hanjun Li; Zhifeng Yu
Journal:  Front Mol Biosci       Date:  2020-11-26

Review 4.  Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors.

Authors:  Hamed Alizadeh Pahlavani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-17       Impact factor: 5.555

Review 5.  Physical Exercise-Induced Myokines in Neurodegenerative Diseases.

Authors:  Banseok Lee; Myeongcheol Shin; Youngjae Park; So-Yoon Won; Kyoung Sang Cho
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

6.  Is high-intensity interval cycling feasible and more beneficial than continuous cycling for knee osteoarthritic patients? Results of a randomised control feasibility trial.

Authors:  Justin W Keogh; Josephine Grigg; Christopher J Vertullo
Journal:  PeerJ       Date:  2018-05-09       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.